What would the Fed do if there are no new jobs or inflation reports by December?
Investors focused on the Computer and Technology space have likely heard of ON Semiconductor (ON), but is the stock performing well in comparison to the rest of its sector peers? Let's take a closer look at the stock's year-to-date performance to find out.
ON Semiconductor is one of 627 individual stocks in the Computer and Technology sector. Collectively, these companies sit at #13 in the Zacks Sector Rank. The Zacks Sector Rank considers 16 different groups, measuring the average Zacks Rank of the individual stocks within the sector to gauge the strength of each group.
The Zacks Rank is a proven system that emphasizes earnings estimates and estimate revisions, highlighting a variety of stocks that are displaying the right characteristics to beat the market over the next one to three months. ON is currently sporting a Zacks Rank of #2 (Buy).
Over the past three months, the Zacks Consensus Estimate for ON's full-year earnings has moved 29.57% higher. This shows that analyst sentiment has improved and the company's earnings outlook is stronger.
Based on the latest available data, ON has gained about 37.03% so far this year. Meanwhile, the Computer and Technology sector has returned an average of 26.63% on a year-to-date basis. This shows that ON Semiconductor is outperforming its peers so far this year.
Breaking things down more, ON is a member of the Semiconductor - Analog and Mixed industry, which includes 10 individual companies and currently sits at #32 in the Zacks Industry Rank. On average, stocks in this group have gained 19.22% this year, meaning that ON is performing better in terms of year-to-date returns.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads.
ON will likely be looking to continue its solid performance, so investors interested in Computer and Technology stocks should continue to pay close attention to the company.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $2.4 trillion by 2028 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Recommendations from previous editions of this report have produced gains of +205%, +258% and +477%. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
ON Semiconductor Corporation (ON): Free Stock Analysis Report
To read this article on Zacks.com click here.
Which stocks should you consider in your very next trade?
The best opportunities often hide in plain sight—buried among thousands of stocks you'd never have time to research individually.
That's why smart investors use our Stock Screener with 50+ predefined screens and 160+ customizable filters to surface hidden gems instantly.
For example, the Piotroski's Picks method averages 23% annual returns by focusing on financial strength, and you can get it as a standalone screen. Momentum Masters catches stocks gaining serious traction, while Blue-Chip Bargains finds undervalued giants.
With screens for dividends, growth, value, and more, you'll discover opportunities others miss. Our current favorite screen is Under $10/share, which is great for discovering stocks trading under $10 with recent price momentum showing some very impressive returns!